SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics
September 16, 2025
SERB Pharmaceuticals, a global specialty pharmaceutical company focused on rare diseases and medical emergencies, today announced the successful completion of its acquisition of Y-mAbs Therapeutics,